How much cefdinir should be given to a 10‑year‑old girl weighing about 30–35 kg with an uncomplicated urinary tract infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for Pediatric UTI

For a 10-year-old girl weighing 30–35 kg with an uncomplicated UTI, cefdinir is not a first-line agent and should generally be avoided in favor of more appropriate alternatives, but if used off-label, the dose would be 14 mg/kg/day (approximately 420–490 mg/day) given either as 7 mg/kg every 12 hours or 14 mg/kg once daily for 7–14 days. 1

Critical Context: Cefdinir Is Not FDA-Approved for UTIs

  • Cefdinir is FDA-approved only for acute bacterial otitis media, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin infections in pediatric patients—NOT for urinary tract infections. 1
  • The FDA label explicitly lists approved indications and UTI is absent from this list, making this an off-label use. 1

Why Cefdinir Is Problematic for UTI Treatment

Guideline-Recommended Alternatives Are Superior

  • The American Academy of Pediatrics recommends a 7–14 day treatment duration for pediatric UTIs, but does not list cefdinir among preferred agents. 2
  • Preferred oral options include: 2
    • Trimethoprim-sulfamethoxazole (84.9% susceptibility)
    • Nitrofurantoin (93.3% susceptibility)
    • Amoxicillin-clavulanate: 20–40 mg/kg/day divided into 3 doses
    • Cefixime: 8 mg/kg/day as a single dose
    • Cefpodoxime: 10 mg/kg/day divided into 2 doses
    • Cephalexin: 50–100 mg/kg/day divided into 4 doses

Evidence Supporting Off-Label Use Is Limited

  • One retrospective study (2003–2004) showed cefdinir had 95.6% susceptibility against common urinary pathogens in children, comparable to ceftriaxone (97.7%) and gentamicin (97.5%). 3
  • However, this same study showed cefdinir had significantly lower activity (64.7%) against opportunistic or nosocomial pathogens. 3
  • A small prophylaxis study (n=14 infants) using 3 mg/kg once daily showed effectiveness for preventing recurrent complicated UTI, but this is a different clinical scenario than acute treatment. 4

If Cefdinir Must Be Used (Off-Label)

Dosing Calculation for This Patient

For a 30–35 kg child: 1

  • Total daily dose: 14 mg/kg/day (maximum 600 mg/day)
  • 30 kg patient: 420 mg/day
  • 35 kg patient: 490 mg/day

Dosing Schedule Options

Two acceptable regimens: 1

  1. Twice-daily dosing: 7 mg/kg every 12 hours (210–245 mg every 12 hours)
  2. Once-daily dosing: 14 mg/kg every 24 hours (420–490 mg once daily)

Important caveat: Once-daily dosing has not been studied specifically for UTIs in the FDA trials, though it was studied for other infections. 1

Duration of Therapy

  • Treat for 7–14 days based on AAP recommendations for pediatric UTIs. 2
  • Shorter courses (1–3 days) are inferior for febrile UTIs. 2

Practical Administration

  • Cefdinir may be given without regard to meals. 1
  • Using the 250 mg/5 mL suspension: 1
    • For 30 kg: 8.4 mL every 12 hours OR 16.8 mL once daily
    • For 35 kg: 9.8 mL every 12 hours OR 19.6 mL once daily
  • Shake suspension well before each dose; discard after 10 days. 1

Clinical Pitfalls and Monitoring

Common Adverse Effects

  • Diarrhea is the most common side effect, occurring in approximately 12.5% of pediatric patients. 5
  • Loose stools were reported in clinical studies but rarely required discontinuation. 6, 4

When to Avoid Cefdinir for UTI

  • If the patient appears toxic or cannot tolerate oral medications, use parenteral therapy initially (typically 24–48 hours until clinical improvement). 2
  • For complicated UTIs or known resistant organisms, choose agents with better evidence and higher susceptibility rates. 3
  • Local antimicrobial resistance patterns should guide therapy; adjust based on culture results. 2

Renal Dosing Adjustments

  • For creatinine clearance <30 mL/min/1.73 m²: reduce dose to 7 mg/kg (up to 300 mg) once daily. 1
  • This is unlikely to apply to a healthy 10-year-old but must be considered if renal impairment exists. 1

Strongly Recommended Alternative Approach

Rather than using off-label cefdinir, consider guideline-concordant options: 2

  • First-line: Trimethoprim-sulfamethoxazole or nitrofurantoin (if local resistance patterns permit)
  • Alternative cephalosporins with better UTI evidence: Cefixime (8 mg/kg/day once daily) or cefpodoxime (10 mg/kg/day divided twice daily)
  • Broad-spectrum option: Amoxicillin-clavulanate (45 mg/kg/day divided three times daily or 90 mg/kg/day divided twice daily, maximum 4000 mg/day)

References

Guideline

Pediatric UTI Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

Research

Prophylactic cefdinir for pediatric cases of complicated urinary tract infection.

Pediatrics international : official journal of the Japan Pediatric Society, 2011

Research

[Clinical evaluation of cefdinir 10% granules in children].

The Japanese journal of antibiotics, 1991

Research

[Pharmacokinetic and clinical studies of cefdinir in pediatric field].

The Japanese journal of antibiotics, 1990

Related Questions

What is the recommended dosage of cefdinir (Omnicef) for children?
Is cefdinir appropriate for a child with a urinary tract infection caused by Escherichia coli or Proteus mirabilis, and what is the recommended dose and duration?
What dose of cefdinir suspension 250 mg/5 mL should be given to a 36‑pound (≈16 kg) child, and how often?
What is the dose of cefdinir (Cefdinir) 250mg/5ml for a 100-pound (approximately 45 kilograms) patient?
What is the appropriate cefdinir liquid dose for a 12‑year‑old child weighing 54 kg?
What empiric intravenous antibiotic regimen should be started for a patient with wound cultures showing gram‑negative rods, gram‑positive cocci in pairs, and gram‑positive rods?
How should I evaluate and manage a patient presenting with ankle pain?
What is the maximum dose of sodium polystyrene sulfonate (Kayexalate) for an adult with serum potassium of 5.6 mEq/L?
Should a 48-year-old woman with stage T2, grade 3 endometrial carcinoma involving the uterine pole, MSH6-deficient (mismatch-repair deficient) and p53 wild-type, and confirmed Lynch syndrome receive adjuvant pelvic radiotherapy?
What is the optimal management, including medication and peri‑operative plan, for a patient with hip synovial chondromatosis and early osteoarthritis who is currently taking tofacitinib 5 mg daily?
When is PCSK9 (proprotein convertase subtilisin/kexin type‑9) genetic testing indicated and what PCSK9‑inhibitor (alirocumab, evolocumab) therapy is recommended for patients with severe or refractory hypercholesterolemia who do not achieve low‑density lipoprotein cholesterol (LDL‑C) targets on maximally tolerated statin therapy ± ezetimibe?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.